BioClonetics Revenue and Competitors
Estimated Revenue & Valuation
- BioClonetics's estimated annual revenue is currently $620k per year.
- BioClonetics's estimated revenue per employee is $155,000
Employee Data
- BioClonetics has 4 Employees.
- BioClonetics grew their employee count by 0% last year.
BioClonetics's People
| Name | Title | Email/Phone |
|---|
BioClonetics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is BioClonetics?
BioClonetics Immunotherapeutics is a biotechnology company with a proprietary methodology and expertise for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. From this methodology, we have created proprietary cell lines that produce fully human monoclonal antibodies that target and neutralize infectious diseases including HIV, influenza, tetanus and diphtheria.
keywords:N/AN/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.9M | 23 | -4% | N/A |
#2 | $7.1M | 33 | -33% | N/A |
#3 | $11.6M | 57 | 21% | N/A |
#4 | $15.1M | 58 | -17% | N/A |
#5 | $15.2M | 69 | -38% | N/A |
